Key Insights

Highlights

Success Rate

85% trial completion

Published Results

12 trials with published results (7%)

Research Maturity

75 completed trials (44% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

7.7%

13 terminated out of 169 trials

Success Rate

85.2%

-1.3% vs benchmark

Late-Stage Pipeline

15%

26 trials in Phase 3/4

Results Transparency

16%

12 of 75 completed with results

Key Signals

12 with results85% success13 terminated

Data Visualizations

Phase Distribution

110Total
Not Applicable (63)
Early P 1 (1)
P 1 (7)
P 2 (13)
P 3 (9)
P 4 (17)

Trial Status

Completed75
Unknown31
Recruiting27
Terminated13
Not Yet Recruiting9
Withdrawn8

Trial Success Rate

85.2%

Benchmark: 86.5%

Based on 75 completed trials

Clinical Trials (169)

Showing 20 of 20 trials
NCT07637721Not ApplicableNot Yet Recruiting

Supraglottic Oxygenation Via Oral Transtracheal Catheter for Reducing the Incidence of Hypoxemia During ERCP Under Sedation

NCT07599605Phase 3CompletedPrimary

Prophylaxis Against Post-Endoscopic Retrograde Cholangio-Pancreatography Pancreatitis.

NCT06691893Phase 3Recruiting

Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients

NCT07330284Not ApplicableRecruitingPrimary

Cold Water Irrigation Therapy as an Adjunct to Indomethacin for Post-Endoscopic Retrograde Cholangiopancreatography(ERCP) Pancreatitis

NCT06691919Not ApplicableWithdrawn

Surgical vs Endoscopic Resection of Walled Off Pancreatic Necrosis Using the Powered Endoscopic Debridement System

NCT02290769Not ApplicableSuspendedPrimary

Time of Cannulation During Primary ERCP With Short Guide Wire Rapid Exchange or With Long Guide Wire

NCT03260387Active Not Recruiting

A Prospective Observational Study of TPIAT

NCT05659147Phase 4Enrolling By InvitationPrimary

Imaging Biomarkers of Pancreatic Function and Disease

NCT06903676Not ApplicableRecruitingPrimary

Utility of Trypsinogen -2 in Early Detection and Follow Up of Post-pancreatectomy Acute Pancreatitis (PPAP)

NCT06721572Not ApplicableCompleted

Role of Home-Based Transcutaneous Electrical Acustimulation for Treatment of Pain in Subjects With Chronic Pancreatitis

NCT07455227Not ApplicableNot Yet RecruitingPrimary

ERCP Management in Mild Gallstone-Induced Pancreatitis Patients Declining Subsequent Cholecystectomy : a Randomized Control Trial.

NCT05160506Phase 2RecruitingPrimary

Corticosteroids to Treat Pancreatitis

NCT02775461Recruiting

Pancreas Registry and High Risk Registry

NCT07381478Phase 2CompletedPrimary

3°C Saline Injection at the Duodenal Papilla to Prevent Post-ERCP Pancreatitis

NCT06386224Not ApplicableRecruitingPrimary

Internet-Delivered Pain Self-Management for Persons With Acute Recurrent and Chronic Pancreatitis Pain

NCT03609944Not ApplicableCompletedPrimary

SpHincterotomy for Acute Recurrent Pancreatitis

NCT07262957Phase 4Recruiting

Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)

NCT07083063Phase 4RecruitingPrimary

Precise Endoscopic Application of Nitroglycerin in Preventing Post-ERCP Pancreatitis

NCT07071441Not ApplicableRecruiting

Indomethacin vs Diclofenac for Preventing PEP

NCT03334708Recruiting

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

Scroll to load more

Research Network

Activity Timeline